tiprankstipranks
Trending News
More News >
Advaxis Inc (ADXS)
:ADXS
Advertisement

Advaxis (ADXS) Price & Analysis

Compare
837 Followers

ADXS Stock Chart & Stats


Advaxis News

ADXS FAQ

What was Advaxis Inc’s price range in the past 12 months?
Advaxis Inc lowest stock price was $0.02 and its highest was $0.80 in the past 12 months.
    What is Advaxis Inc’s market cap?
    Advaxis Inc’s market cap is $1.46M.
      When is Advaxis Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Advaxis Inc’s earnings last quarter?
      Currently, no data Available
      Is Advaxis Inc overvalued?
      According to Wall Street analysts Advaxis Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Advaxis Inc pay dividends?
        Advaxis Inc does not currently pay dividends.
        What is Advaxis Inc’s EPS estimate?
        Advaxis Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Advaxis Inc have?
        Advaxis Inc has 42,633,400 shares outstanding.
          What happened to Advaxis Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Advaxis Inc?
          Currently, no hedge funds are holding shares in ADXS

          Company Description

          Advaxis Inc

          Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

          Advaxis (ADXS) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          Salarius Pharmaceuticals
          Processa Pharmaceuticals
          GRI Bio
          Protagenic Therapeutics
          ZyVersa Therapeutics

          Ownership Overview

          58.95%<0.01%100.00%
          58.95% Insiders
          <0.01% Other Institutional Investors
          100.00% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis